.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
LA Family Farms is stocked at 57 licensed dispensaries across California, with the deepest coverage in Los Angeles, Santa Ana, San Bernardino, San Diego, and El Monte. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In August 2026, LA Family Farms pivoted heavily toward Concentrates, which expanded to 61.21% share with 626.10% year-over-year growth and 81.40% month-over-month momentum, while Flower contracted to 21.05% share with a -61.23% YoY decline and -47.12% MoM drop. Pre-Roll fell to 17.74% share with -32.72% YoY and -53.31% MoM, and the brand’s average price declined -10.61% YoY to $35.31 even as Concentrates held a $39.38 average. The brand’s rank in California Concentrates is 43, indicating a mid-pack position despite the mix shift. Together, the surge in Concentrates alongside steep pullbacks in Flower and Pre-Roll implies a deliberate consolidation around a faster-velocity segment to offset weakness in legacy formats and stabilize total sales growth of 10.12% YoY.
The mix realignment concentrates demand into a category where LA Family Farms holds rank 43, which, paired with 81.40% MoM and 626.10% YoY in Concentrates, suggests runway for share capture if pricing discipline continues relative to the -10.61% brand-wide YoY price change. With Flower and Pre-Roll contracting by -47.12% and -53.31% MoM respectively, the portfolio now relies on a single growth engine, elevating execution risk but also clarifying positioning around higher-ticket inhalables at $39.38 versus $22.94 in Pre-Roll. The pattern implies LA Family Farms is trading breadth for depth: leaning into Concentrates to improve rank trajectory in California while allowing underperforming categories to deflate to protect margin and velocity.
Competitive Landscape
LA Family Farms ranks #43 in California Concentrates in August 2026, improving 89 positions year over year from #132 while climbing 33 spots since May 2026 from #76, and this new #43 also marks its peak rank. By contrast, Raw Garden holds #1 with a 9.9% year-over-year sales increase, and 710 Labs advanced from #4 to #2 alongside a 33.5% sales lift, whereas STIIIZY sits at #3 with a -2.3% year-over-year decline. The combination of an 89-place annual gain and a 33-place three-month surge indicates LA Family Farms is transitioning from long-tail visibility toward mid-pack relevance, implying runway to test price-pack architecture and retail penetration before encountering the top-five ceiling.
Notable Products
Lemosa x Zamosa Pre-Roll (2g) posted the steepest movement in August 2026 with a -54.2% month-over-month decline and slipped behind higher-ranked Concentrates that held ranks 1 and 2, while Whiplash x Sakura Pre-Roll (2g) fell -47.1% and could not break into the top 5. Peach Z Live Hash Rosin (1g) led the lineup at rank 1 with Concentrates occupying 4 of the top 5 positions, and Zamosa Rosin (1g) followed at rank 2 as Pre-Rolls clustered lower at ranks 4 and 6. This pattern implies LA Family Farms is consolidating demand around premium rosin formats while deprioritizing heavier Pre-Roll pushes as volatility rises.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
